Stoichiometry of the murine γδ T cell receptor by Hayes, Sandra M. & Love, Paul E.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
BRIEF DEFINITIVE REPORT
Vol. 203, No. 1,  January 23, 2006  47–52  www.jem.org/cgi/doi/10.1084/jem.20051886 47
<doi>10.1084/jem.20051886</doi><aid>20051886</aid>Stoichiometry of the murine 𝗄𝗅 
T cell receptor 
Sandra M. Hayes and Paul E. Love
Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, 
National Institutes of Health, Bethesda, MD 20892
The T cell receptor for antigen (TCR) complex is organized into two functional domains: the 
antigen-binding clonotypic heterodimer and the signal-transducing invariant CD3 and TCR𝗇 
chains. In most vertebrates, there are two different clonotypic heterodimers (TCR𝗂𝗃 and 
TCR𝗄𝗅) that defi  ne the 𝗂𝗃 and 𝗄𝗅 T cell lineages, respectively. 𝗂𝗃- and 𝗄𝗅TCRs also differ 
in their invariant chain subunit composition, in that 𝗂𝗃TCRs contain CD3𝗄𝗆 and CD3𝗅𝗆 
dimers, whereas 𝗄𝗅TCRs contain only CD3𝗄𝗆 dimers. This difference in subunit composition 
of the 𝗂𝗃- and 𝗄𝗅TCRs raises the question of whether the stoichiometries of these recep-
tor complexes are different. As the stoichiometry of the murine 𝗄𝗅TCR has not been previ-
ously investigated, we used two quantitative immunofl  uorescent approaches to determine 
the valency of TCR𝗄𝗅 heterodimers and CD3𝗄𝗆 dimers in surface murine 𝗄𝗅TCR complexes. 
Our results support a model of murine 𝗄𝗅TCR stoichiometry in which there are two CD3𝗄𝗆 
dimers for every TCR𝗄𝗅 heterodimer.
The multimeric TCR is composed of an anti-
gen-binding clonotypic heterodimer (TCRαβ 
or TCRγδ) and a signal-transducing complex, 
consisting of the CD3 dimers (CD3γε and/or 
CD3δε) and a TCRζ homodimer. TCR sig-
naling is required for lineage commitment and 
  repertoire selection during development, for 
maintenance of the peripheral T cell pool, and 
for diff  erentiation of naive T cells into eff  ector 
and memory cell populations during an immune 
response. Despite the fact that many of the com-
ponents of the TCR-coupled signaling path-
ways have been elucidated, it is not precisely 
known how these signaling events are initially 
triggered. Two models have been proposed to 
provide a mechanism for the initiation of TCR 
signal transduction, with each implicating a dis-
tinct stoichiometry for the TCR (for reviews 
see references 1 and 2). In the fi  rst model, 
the surface TCR complex contains one TCR 
heterodimer, two CD3 dimers, and one TCRζ 
homodimer (3–6). According to this monova-
lent TCR model, ligand engagement would 
initiate signaling by conformational changes in 
the subunits and/or by oligomerization of indi-
vidual TCR complexes. The second model, 
known as the bivalent TCR model, proposes 
that the surface TCR complex contains two 
clonotypic heterodimers, two CD3 dimers, and 
one TCRζ homodimer (7–10). Triggering of 
the bivalent TCR complex may still require a 
conformational change in the subunits, but the 
presence of two TCR heterodimers within a 
single TCR complex would preclude the need 
for receptor oligomerization.
Most studies of TCR stoichiometry have 
been performed on the αβTCR and, conse-
quently, little is known about the stoichiome-
try of γδTCR. We recently provided evidence 
to suggest that the stoichiometry of the γδTCR 
diff  ers from that of the αβTCR. Specifi  cally, 
whereas αβTCRs contain both CD3δε and 
CD3γε dimers, most γδTCRs were found to 
contain only CD3γε dimers (11). However, 
these experiments did not resolve whether one 
or two CD3γε dimers are incorporated into 
the fully assembled γδTCR complex. Interest-
ingly, signal transduction by the γδTCR was 
shown to be superior to that of the αβTCR 
after cross-linking of CD3 alone (11). A multi-
valent γδTCR complex could explain this en-
hanced signaling capacity of the γδTCR. To 
determine the stoichiometry of the γδTCR, 
we developed two quantitative immunofl  uo-
rescence techniques to measure (a) the ratio 
of CD3 dimers to TCRγδ heterodimers and 
(b) the relative percentage of CD3γε dimers 
on the surface of polyclonal γδ T cells. In this 
paper, we report fi  ndings that favor a monova-
lent model for γδTCR stoichiometry.
CORRESPONDENCE
Sandra M. Hayes:
hayessa@upstate.edu48   STOICHIOMETRY OF THE MURINE γδ T CELL RECEPTOR | Hayes and Love 
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Quantifying the ratio of CD3𝗆 dimers to TCR𝗄𝗅 
heterodimers on the surface of murine 𝗄𝗅 T cells
There are three possible models for the stoichiometry of the 
murine γδTCR. Two of these (Fig. 1, A and B) are based on 
the present models proposed for the stoichiometry of the 
αβTCR. The confi  guration in Fig. 1 A is based on the 
monovalent αβTCR model (3–6) and depicts the surface 
γδTCR complex with one TCRγδ heterodimer, two 
CD3γε dimers, and one TCRζ homodimer, for a total of 
eight subunits. The confi  guration in Fig. 1 B is based on the 
alternative bivalent αβTCR model (7–10) and depicts the 
surface  γδTCR complex with 2 TCRγδ heterodimers, 
2 CD3γε dimers, and 1 TCRζ homodimer, for a total of 10 
subunits. It is also conceivable that the rules of γδTCR as-
sembly and surface expression diff   er from those of the 
αβTCR, such that a γδTCR complex containing only one 
CD3γε dimer is transported to and stably expressed on the 
cell surface. This surface complex would contain one TCRγδ 
heterodimer, one CD3γε dimer, and one TCRζ homodi-
mer, for a total of six subunits (Fig. 1 C). As the CD3ε/
TCRγδ ratio varies in the confi  gurations shown in Fig. 1, 
quantifying this ratio is the fi  rst step in solving the stoichiom-
etry of the murine γδTCR. To this end, we developed a 
fl  ow cytometric approach similar to those used by others to 
quantify the CD3ε/TCR ratio on primary mouse and hu-
man T cells (4, 12). This method takes advantage of the fact 
that the mAbs against CD3γε/δε dimers (2C11) and TCRγδ 
heterodimers (GL3, GL4, UC7-13D5, and UC3-10A6) are 
all hamster IgG antibodies containing κ light chains. As each 
primary antibody can be detected with the same anti–hamster 
Igκ secondary antibody, the relative expression levels of CD3 
dimers and TCRγδ heterodimers on the surface of γδ T cells 
can be measured if saturating amounts of mAb are used. Our 
approach diff  ers from those of previous studies in that we 
used a monoclonal anti–hamster antibody instead of poly-
clonal anti–hamster IgG antibodies, thereby restricting rec-
ognition to a single epitope on each primary antibody. 
A representative staining profi  le for anti-CD3γε/δε (2C11) 
and two anti-TCRγδ (GL3 and UC7-13D5) mAbs on gated 
CD4−CD8−CD19− LN cells from TCRβ−/− mice is shown 
in Fig. 2 A. Note that the relative fl  uorescence of 2C11 mAb 
staining is approximately twice that of anti-TCRγδ mAb 
staining, regardless of which anti-TCRγδ mAb was used 
(GL3, GL4, UC7-13D5, or UC3-10A6; Fig. 2, A and B). 
These results indicate that there are two CD3 dimers for ev-
ery TCRγδ heterodimer on the surface of γδ T cells. Impor-
tantly, loss of CD3δ expression does not aff  ect this ratio, 
because we also observed two CD3 dimers for every TCRγδ 
heterodimer on the surface of CD4−CD8− TCRβ−CD19− 
LN cells from CD3δ−/− mice (Fig. 2 B). This fi  nding is con-
sistent with previous results demonstrating that neither TCRδ 
nor TCRγ pairs effi   ciently to a CD3δε dimer (11). The ob-
served 2:1 ratio of CD3 dimers to TCRγδ heterodimers 
  favors the monovalent TCR model shown in Fig. 1 A, in 
which there is one TCRγδ heterodimer and two CD3 dimers 
in each γδTCR complex. Thus, our fi  ndings indicate that the 
γδTCR has a signal transducing complex that is similar to that 
of the αβTCR, in that it contains two CD3 dimers.
Quantifying the relative percentage of CD3𝗄𝗆 dimers 
on the surface of murine 𝗄𝗅 T cells
Biochemical analysis suggests that a small percentage of sur-
face γδTCR complexes contain CD3δε dimers (11, 13). The 
γδTCRs that contain CD3δε dimers could be restricted to a 
distinct subpopulation of γδ T cells or may represent a minor 
subset of TCRs on each γδ T cell. To discern between 
these two possibilities, we developed a second fl  ow cyto-
metric assay that uses an anti-CD3γε mAb (7D6), which has 
been reported to block the binding of the 2C11 mAb to 
CD3γε dimers but not to CD3δε dimers (14). To confi  rm 
the specifi  city of the 7D6 mAb and its ability to block 2C11 
Figure 1.  Possible confi  gurations for the murine 𝗄𝗅TCR complex. (A) Monovalent γδTCR model. (B) Bivalent γδTCR model. (C) One CD3γε 
dimer model.JEM VOL. 203, January 23, 2006  49
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mAb staining of CD3γε dimers, we assayed double-negative 
(DN) thymocytes from CD3δ−/−, CD3γ−/−, and CD3ε−/− 
mice (Fig. 3 A). The 7D6 mAb detected the intracellular 
CD3γε dimers present in CD3δ−/− DN thymocytes but not 
the intracellular CD3δε dimers present in CD3γ−/− DN 
thymocytes. In addition, pretreatment with the 7D6 mAb 
completely blocked 2C11 mAb staining of intracellular 
CD3γε dimers in CD3δ−/− DN thymocytes but had no ef-
fect on 2C11 mAb staining of intracellular CD3δε dimers in 
CD3γ−/− DN thymocytes. Next, we tested the effi   cacy of 
this fl  ow cytometric approach. We fi  rst assayed γδ T cells 
from CD3δ−/− mice, which express only CD3γε dimers on 
their cell surface (13), and found that the 7D6 mAb was in-
deed able to completely block 2C11 mAb surface staining 
(Fig. 3 B). We then assayed CD4+ αβ T cells from B6 mice, 
which express both CD3γε and CD3δε dimers on their cell 
surface (for review see reference 15) and found, as expected, 
that the 7D6 mAb only partially blocked 2C11 mAb surface 
staining (Fig. 3 B). If expression of γδTCRs containing 
CD3δε dimers were limited to a subpopulation of γδ T cells, 
then pretreatment with purifi  ed 7D6 mAb should partially 
block 2C11 staining on this CD3δ+ subset and completely 
block 2C11 staining on the CD3δ− subset. However, if 
CD3δε containing γδTCRs were a minor subset of TCRs 
expressed on each γδ T cell, then pretreatment with purifi  ed 
7D6 mAb should almost completely block 2C11 staining on 
all γδ T cells. We found that when γδ T cells from TCRβ−/− 
mice were assayed, the 7D6 mAb almost completely blocked 
the staining of the 2C11 mAb, indicating that the TCRs con-
taining CD3δε dimers represent a minor subset of TCRs 
  expressed on each γδ T cell (Fig. 3 B). In fact, the relative 
percentage of CD3γε dimers was calculated to be 99.2 ± 0.1% 
of all CD3 dimers.
CD3𝗄 is absolutely required for the assembly and expression 
of the 𝗄𝗅TCR
If two CD3γε dimers are found in each surface γδTCR 
complex, then the loss of CD3γ should have profound eff  ects 
on γδTCR assembly and surface expression. Indeed, Haks 
et al. have reported that γδ T cell development is severely af-
fected in CD3γ−/− mice (16). We sought to expand these 
earlier experiments by performing a more detailed analysis of 
γδTCR surface expression on thymocytes and splenocytes 
from CD3γ−/− mice and from CD3γ−/− mice carrying a 
γδTCR transgene. Virtually no γδTCR+ cells were detected 
in the thymus and spleen of CD3γ−/− mice (Fig. 4, A and B). 
Moreover, introduction of a γδTCR transgene into CD3γ−/− 
mice did not increase the number of γδTCR+ thymocytes 
and splenocytes as it does when introduced into CD3γ+/+ 
mice, indicating that the absence of γδTCR+ cells in 
CD3γ−/− mice cannot solely be caused by a failure to express 
productively rearranged TCRγ and -δ genes (Fig. 4 A). 
These fi  ndings demonstrate that γδTCR assembly and sur-
face expression are absolutely dependent on the presence of 
CD3γ. Remarkably, unlike the γδTCR, the αβTCR can 
still be expressed on the surface of CD3γ−/− thymocytes and 
splenocytes, albeit at reduced levels compared with CD3γ+/+ 
cells (Fig. 4 C) (16). Therefore, CD3γ−/− mice reveal a dif-
ference in the requirement for CD3γ in αβ- and γδTCR as-
sembly and surface expression. Importantly, this diff  erence is 
consistent with the supposition that TCRγ and -δ chains 
each pair with a CD3γε dimer but not a CD3δε dimer.
Concluding remarks
Using quantitative immunofl  uorescence techniques, we have 
addressed the issue of murine γδTCR stoichiometry. We 
observed a 2:1 ratio of CD3 dimers to TCRγδ heterodimers 
on the surface of peripheral γδ T cells, a ratio that supports 
the monovalent TCR model (Fig. 1 A). We also present new 
evidence, in accordance with previously reported biochemi-
cal data (11, 13), demonstrating that the two CD3 dimers 
contained within the γδTCR are almost exclusively CD3γε 
dimers. Lastly, an analysis of γδTCR surface expression on 
CD3γ−/− thymocytes and splenocytes revealed an absolute 
requirement for CD3γε dimers in γδTCR assembly. To-
gether, these data strongly support the idea that, during 
γδTCR assembly, both TCRγ and TCRδ pair with a 
CD3γε dimer. In this study, the ratio of TCRζ homodimers 
Figure 2.  Comparison of CD3 and TCR𝗄𝗅 surface levels on murine 
𝗄𝗅 T cells. (A) Histogram showing the relative fl  uorescence of 2C11, GL3, 
and UC7-13D5 (UC7) mAb staining on gated CD4−CD8−CD19− LN cells 
from TCRβ−/− mice. The 2C11 mAb (dark gray line) recognizes both CD3γε 
and CD3δε dimers, and the GL3 (bold line) and UC7 (light gray line) mAbs 
recognize TCRγδ heterodimers. Staining with a hamster isotype control is 
also shown (shaded histogram). The number in parentheses represents the 
mean fl  uorescence intensity for each mAb minus that of the hamster 
isotype control. (B) Ratio of CD3ε/TCRγδ (for calculation information see 
Materials and methods) for each anti-TCRγδ mAb on the surface of 
CD4−CD8−CD19− LN cells from TCRβ−/− mice (GL3, n = 10; GL4, n = 3; 
UC7, n = 10; UC3, n = 3) and CD4−CD8−TCRβ−CD19− LN cells from 
CD3δ−/− mice (GL3, n = 8; GL4, n = 4; UC7, n = 8; UC3, n = 3). Bars 
represent the means ± standard deviation.50   STOICHIOMETRY OF THE MURINE γδ T CELL RECEPTOR | Hayes and Love 
to CD3 dimers or TCRγδ heterodimers was not measured 
and, therefore, the number of TCRζ homodimers contained 
within a surface γδTCR complex cannot be determined. 
However, based on the conservation of positively charged 
residues in the transmembrane regions of all four TCR chains 
that are required for association with the invariant TCR 
chains (for review see reference 15), we propose that, like the 
αβTCR, the γδTCR contains one TCRζ homodimer.
The vast majority of murine γδTCRs, whether expressed 
on naive or activated γδ T cells, contain only CD3γε dimers 
(Fig. 3 and not depicted) (11, 13). It is not clear, however, 
whether human γδTCRs share the same bias for CD3γε di-
mers. Biochemical analysis of surface γδTCR complexes on 
primary human γδ T cells detected some CD3δε dimers but 
considerably less than the amount observed in surface αβTCR 
complexes on primary human αβ T cells (11). Interestingly, 
biochemical analysis of surface γδTCR complexes on acti-
vated and expanded human γδ T cell clones detected CD3δε 
dimers in amounts comparable to those seen in surface 
αβTCRs (unpublished data) (17). Unfortunately, CD3δ de-
fi  ciency in humans does not resolve the issue of whether 
CD3δ is required for human γδTCR surface expression, be-
cause it is not known whether the absence of peripheral γδ 
T cells (18, 19) is caused by the loss of CD3δ or by the 
markedly reduced levels of the other invariant subunits that 
accompany CD3δ defi  ciency in the patients analyzed (18). 
Nevertheless, these fi  ndings suggest that there may be impor-
tant diff  erences in the subunit requirements for murine and 
human γδTCR assembly. It is believed, based on sequence 
homology, that TCRδ is the counterpart to TCRα and, 
consequently, that TCRδ should pair preferentially with 
CD3δε dimers (for review see reference 15). Accordingly, 
the inconsistency in murine and human γδTCR assembly 
can be explained by a diff  erence in either the binding affi   n-
ities of the respective TCRδ chains for CD3δε dimers or the 
binding affi   nities of the respective CD3δε dimers for TCRδ 
chains. Murine TCRδ pairs to a CD3γε dimer but not to a 
CD3δε dimer (Figs. 2 and 3) (11, 13). However, this is not 
the case for human TCRδ, as a metabolic labeling study us-
ing TCRαβ− Jurkat cells transfected with a human TCRδ 
Figure 3.  Quantifying the relative percentage of CD3𝗄𝗆 dimers on 
the surface of murine 𝗄𝗅 T cells. (A) Intracellular staining (ic) of CD3 
dimers in gated DN thymocytes from CD3γ−/− (bold line) and CD3δ−/− 
mice (gray line) using FITC-conjugated 2C11 (anti-CD3γε/δε) and Alexa 
488–conjugated 7D6 (anti-CD3γε) mAbs. DN thymocytes are defi  ned as
 CD4−CD8−CD19−TCRγδ−TCRβ−NK1.1−DX5−. Gated DN thymocytes from 
CD3ε−/− mice were used as a negative staining control (shaded histogram). 
Staining without (top) and with (bottom) 7D6 mAb blocking is shown. 
(B) Surface (s) staining of CD3 dimers on gated γδTCR+ CD4−CD8− LN cells 
from CD3δ−/− and TCRβ−/− mice and on gated αβTCR+ CD4+ LN cells 
from B6 mice using 2C11–FITC and 7D6–Alexa 488 mAbs. (top) Surface 
staining of 7D6–Alexa 488 mAb alone (bold line) and after blocking with 
purifi  ed 7D6 mAb (shaded histogram). (bottom) Surface staining of 2C11–
FITC mAb alone (gray line), after blocking with purifi  ed 7D6 mAb (bold line), 
and after blocking with purifi  ed 2C11 mAb (shaded histogram). The mean 
relative percentage of CD3γε dimers on γδTCR+ CD4−CD8− LN cells from 
TCRβ−/− mice (n = 4; for calculation see Materials and methods) ± stan-
dard deviation is shown.JEM VOL. 203, January 23, 2006  51
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gene shows that human TCRδ can associate with either hu-
man CD3γε or CD3δε (20). Remarkably, in the same study, 
when a murine TCRδ gene was transfected into the TCRαβ− 
Jurkat variant, the murine TCRδ was also shown to pair with 
either human CD3γε or CD3δε. Collectively, these data in-
dicate that murine and human CD3δε dimers diff  er in their 
ability to bind to TCRδ chains.
Of the current models of TCR stoichiometry, the ob-
served 2:1 ratio of CD3 dimers to TCRγδ heterodimers fa-
vors the monovalent TCR model for γδTCR stoichiometry 
(Fig. 1 A). However, we cannot rule out the possibility that 
monovalent γδTCR complexes cluster or aggregate on the 
cell surface to form higher order complexes. If these higher 
order complexes exist, they may provide an explanation for 
how signal transduction by the γδTCR is superior to that of 
the αβTCR in the absence of coreceptor involvement. The 
diff  erence in the subunit composition of the αβ- and γδTCR 
signal transducing complexes may also explain the increased 
signaling profi  ciency of the γδTCR. As the amino acid se-
quence of the immunoreceptor tyrosine-based activation 
motif in each CD3 chain is unique (for review see reference 
21), it is conceivable that αβ- and γδTCR complexes recruit 
distinct signaling molecules. In addition, or alternatively, in-
trinsic diff  erences in the signaling pathways coupled to αβ- 
and  γδTCRs may provide a mechanism by which the 
γδTCR is capable of signaling better than the αβTCR.
MATERIALS AND METHODS
Mice. B6.129P2-TCRβ−/− (TCRβ−/−) mice (22) were purchased from 
the Jackson Laboratory. C57BL/6-CD3δ−/− (CD3δ−/−) mice (23) were 
provided by D. Kappes (Fox Chase Cancer Center, Philadelphia, PA), and 
129-CD3γ−/− (CD3γ−/−) mice (16) were provided by D. Wiest (Fox Chase 
Cancer Center). C57BL/6-Vγ6/Vδ1 γδTCR transgenic (Tg) mice (line 
134) (24) were provided by B.J. Fowlkes (National Institutes of Health 
[NIH], Bethesda, MD). B6.129-CD3ε−/− (CD3ε−/−) (25) and C57BL/6 
(B6) mice were generated in our colony. Mice were bred and maintained in 
an NIH Research Animal Facility in accordance with the specifi  cations of 
the Association for Assessment and Accreditation of Laboratory Animal 
Care. Mouse protocols were approved by the NIH Animal Care and Use 
Committee. All mice were killed at 8–12 wk of age.
Antibodies and reagents. mAbs used for fl  ow cytometric analysis included 
anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-TCRγδ (GL3, GL4, and 
UC7-13D5), anti-Vγ4 (UC3-10A6), anti-TCRβ (H57-597), anti-CD3ε 
(145-2C11), anti-CD19 (1D3), and a hamster IgG isotype control, all of 
which were purchased from BD Biosciences. The secondary reagent, biotin-
conjugated anti–hamster Igκ (HIG-29), was also purchased from BD Biosci-
ences. The anti-CD3γε (7D6) hybridoma (14) was obtained from A. Singer 
(NIH, Bethesda, MD) and D. Wiest and was used to produce ascites. Protein 
A/G–purifi  ed 7D6 mAb was conjugated to AlexaFluor 488 according to the 
manufacturer’s instructions (Invitrogen). AlexaFluor 488 conjugated to 
streptavidin was also purchased from Invitrogen.
Flow cytometry. Flow cytometric analysis for surface antigens was per-
formed as previously described (26). Intracellular staining for CD3 dimers 
was performed (Cytofi  x/Cytoperm kit; BD Biosciences) according to the 
manufacturer’s instructions. The ratio of CD3 dimers to TCRγδ heterodi-
mers was determined using an assay previously described for determining the 
ratio of CD3 dimers to TCRαβ heterodimers (4, 12). In brief, 1.5 × 106 
lymph node cells were incubated with saturating amounts of purifi  ed anti-
TCRγδ (GL3, GL4, UC7-13D5, or UC3-10A6) and anti-CD3ε (145-
2C11) mAbs for 30 min on ice. Saturating amounts of antibody are defi  ned 
as the concentration of purifi  ed antibody required to completely block the 
binding of the same antibody conjugated to a fl  uorochrome. All fi  ve mAbs 
are hamster IgG that use the Igκ light chain. Accordingly, their relative 
binding intensities can be assayed using saturating amounts of the same 
Figure 4.  Phenotypic analysis of CD3𝗄−/− and 𝗄𝗅TCR Tg CD3𝗄−/− 
mice. (A) Comparison of γδTCR surface levels on DN thymocytes and 
splenocytes from CD3γ−/− (bold line) and CD3γ+/+ (gray line) mice 
(top) and from γδTCR Tg CD3γ−/− (bold line) and γδTCR Tg CD3γ+/+ 
(gray line) mice (bottom). DN thymocytes and splenocytes are defi  ned as 
CD4−CD8−CD19−. Staining with a hamster isotype control is also shown 
(shaded histogram). (B) Number of γδTCR+ CD4−CD8−CD19− cells in the 
thymus and spleen of CD3γ+/+ (n = 4) and CD3γ−/− (n = 6) mice. Bars 
represent means ± standard deviation. (C) Comparison of αβTCR surface 
levels on CD4+ thymocytes and splenocytes from CD3γ+/+ (gray line) and 
CD3γ−/− (bold line) mice. Staining with a hamster isotype control is also 
shown (shaded histogram).52   STOICHIOMETRY OF THE MURINE γδ T CELL RECEPTOR | Hayes and Love 
anti–  hamster secondary mAb, biotin-conjugated anti–hamster Igκ (HIG-
29). The CD3ε/TCRγδ ratio was calculated using the following equation, 
where MFI stands for mean fl  uorescence intensity:
MFI(2C11)  MFI(hamster isotype control)
MFI(TCR )  MFI(h
  
      a amster isotype control)
The relative percentage of CD3γε dimers in CD3 dimers on the surface 
of γδ T cells was determined using saturating amounts of anti-CD3γε (7D6; 
300 μg/ml for intracellular staining and 200 μg/ml for surface staining) mAb to 
block the binding of CD3γε dimers by anti-CD3ε (145-2C11) mAb (14). The 
percentage of CD3γε dimers was calculated using the following equation:
1  
MFI(2C11   7D6 block)    2C11   2C11 block
2C11
 
    MFI( )
MFI( ) )M F I ( )     2C11   2C11 block
  
  
  100
For all experiments, 2–4 × 105 cells were collected (FACSCalibur; Bec-
ton Dickinson) using CellQuest software or LSR II using FACSDiva soft-
ware (BD Immunocytometry Systems) and analyzed using FlowJo software 
(Tree Star, Inc.). Dead cells were excluded from analysis based on forward 
and side scatter profi  les.
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